← Back to Search
Macromolecular Carrier Systems For Targeted Drug Delivery: Pharmacokinetic Considerations On Biodistribution
Y. Takakura, M. Hashida
Published 2004 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
This review article describes the current status and future perspectives of site-specific drug delivery by means of macromolecular carrier systems. Basic aspects and recent advances of targeted delivery of 1) conventional drugs, 2) protein drugs, and 3) gene medicines including antisense oligonucleotides and plasmid DNA, are reviewed from a pharmacokintic perspective. Successful in vivo application of macromolecular carrier systems requires pharmacokinetic considerations at whole body, organ, cellular and subcellular levels. The integration of simultaneous research progress in the multidisciplinary fields such as biochemistry, cell and molecular biology, pharmacology, and pharmacokinetics will accelerate the emergence of marketed drugs with macromolecular carrier systems.
This paper references
Soluble macromolecular carriers for the delivery of antitumour drugs
H. Sezaki (1989)
Vascular targeting--a new approach to the therapy of solid tumors.
F. Burrows (1994)
Complete sequence of the mitochondrial DNA of the chlorophyte alga Prototheca wickerhamii. Gene content and genome organization.
G. Wolff (1994)
Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression.
G. Wu (1994)
Generation of cytotoxic agents by targeted enzymes.
P. Senter (1993)
Pharmacokinetics of succinylated proteins and dextran sulfate in mice : implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors
Takakura Yoshinobu (1994)
The clinical efficacy of poly(ethylene glycol)-modified proteins
Friedericka Fuertges (1990)
Targeting of genes to the liver with glycoprotein carriers
J. Frese (1994)
Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
M. Monsigny (1994)
Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
C. Sung (1990)
Pharmacokinetics of Drug Targeting: Specific Implications for Targeting via Prodrugs
V. Stella (1991)
Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis
M. Hashida (1997)
Synthesis and Pharmacokinetics of a New Liver-Specific Carrier, Glycosylated Carboxymethyl-Dextran, and Its Application to Drug Targeting
M. Nishikawa (2004)
The conjugation of proteins with polyethylene glycol and other polymers: Altering properties of proteins to enhance their therapeutic potential
N. Katre (1993)
Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.
K. Widder (1979)
Hepatic Disposition Characteristics of Electrically Charged Macromolecules in Rat in Vivo and in the Perfused Liver
K. Nishida (2004)
Cell surface actions of adriamycin.
T. Tritton (1991)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
F. Yuan (1995)
Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice.
A. Takagi (1995)
Design for Cell-Specific Targeting of Proteins Utilizing Sugar-Recognition Mechanism: Effect of Molecular Weight of Proteins on Targeting Efficiency
M. Nishikawa (2004)
2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins.
Y. Lee (1976)
Drug targeting to the kidney with low-molecular-weight proteins
E. Franssen (1994)
Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
E. Wagner (1994)
A novel gene delivery system using EGF receptor‐mediated endocytosis
J. Chen (1994)
An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes.
J. C. Perales (1994)
Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
M. Nishikawa (1995)
The Blood-brain barrier : cellular and molecular biology
W. Pardridge (1993)
Tumoritropic and lymphotropic principles of macromolecular drugs.
H. Maeda (1989)
Stability and pharmacokinetic characteristics of oligonucleotides modified at terminal linkages in mice.
T. Miyao (1995)
Disposition and Tumor Localization of Mitomycin C–Dextran Conjugates in Mice
Y. Takakura (2004)
Control of the disposition profiles of proteins in the kidney via chemical modification
Y. Takakura (1994)
Trends and Future Perspectives in Peptide and Protein Drug Delivery
V. H. Lee (1995)
Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.
Y. Takakura (1995)
The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake
K. Kawabata (2004)
Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
G. Citro (1994)
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
L. Seymour (1991)
Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion.
T. Fujita (1992)
Hepatic endocytosis of various types of mannose-terminated albumins. What is important, sugar recognition, net charge, or the combination of these features.
R. W. Jansen (1991)
Receptor-Mediated Transport of Peptide Hormones and Its Importance in the Overall Hormone Disposition in the Body
Y. Sugiyama (2004)
Targeting of antiviral drugs to the liver using glycoprotein carriers
L. Fiume (1994)
Enhancement of tumouricidal activity of daunomycin by receptor-mediated delivery. In vivo studies.
B. Mukhopadhyay (1993)
Delivery of peptides and proteins through the blood-brain barrier.
U. Bickel (2001)
Follow‐up Study of Patients Treated with Monoclonal Antibody‐Drug Conjugate: Report of 77 Cases with Colorectal Cancer
T. Takahashi (1993)
Antisense Research and Application
T. Akiyama (1998)
Synthesis of a superoxide dismutase derivative that circulates bound to albumin and accumulates in tissues whose pH is decreased.
M. Inoue (1989)
Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol.
K. Mihara (1994)
Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor.
T. Ferkol (1993)
Galactosylated histone-mediated gene transfer and expression.
J. Chen (1994)
Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.
J. C. Perales (1994)
Disposition Characteristics of Macromolecules in Tumor-Bearing Mice
Y. Takakura (2004)
Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism.
Y. Takakura (1994)
Vector-mediated peptide drug delivery to the brain
W. Pardridge (1995)
Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells.
J. Turek (1993)
Tumor Localization and in vivo Antitumor Activity of the Immunoconjugate Composed of Anti‐human Colon Cancer Monoclonal Antibody and Mitomycin C‐Dextran Conjugate
A. Noguchi (1991)
Chemotherapy through lysosomes with a DNA-daunorubicin complex.
A. Trouet (1972)
Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.
M. Buschle (1995)
Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.
T. Fujita (1992)
Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
A. Epstein (1995)
Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour Lw (1992)
Macromolecule-drug conjugates in targeted cancer chemotherapy.
H. Sezaki (1984)
This paper is referenced by
Synthesis and molecular recognition of novel oligo(ethylenediamino) bridged bis(beta-cyclodextrin)s and their copper(II) complexes: enhanced molecular binding ability and selectivity by multiple recognition.
Y. Liu (2001)
Cell-specific delivery of genes with glycosylated carriers.
M. Hashida (2001)
Enzymatic synthesis of acyclovir–galactose conjugate with liver targeting and anti-HBV activity
B. Jiang (2008)
In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
Xiaoqian Shan (2009)
Slow-targeted release of a ruthenium anticancer agent from vitamin B12 functionalized marine diatom microalgae.
Joachim Delasoie (2018)
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.
B. Říhová (2000)
Development of gene drug delivery systems based on pharmacokinetic studies.
Y. Takakura (2001)
alpha,beta-poly(asparthylhydrazide)-glycidyltrimethylammonium chloride copolymers (PAHy-GTA): novel polymers with potential for DNA delivery.
E. Pedone (2001)
Nanobiotechnology in drug delivery
N. Azad (2006)
Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels.
A. Mikhail (2009)
Block Copolymer Micelles for Controlled Delivery of Glycolytic Enzyme Inhibitors
S. Akter (2011)
Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA
R. Mahato (2005)
Cross-linked nanoassemblies from poly(ethylene glycol)-poly(aspartate) block copolymers as stable supramolecular templates for particulate drug delivery.
Hyun Jin Lee (2011)
Development of polymer and lipid based nano-delivery systems for targeted cancer chemotherapy
Mostafa Shahin (2012)
Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice
W. Yeeprae (2005)
Micellization and Structure of MOPEO‐b‐PCL Copolymers and Their Application as Nanocontainers for Drugs
Sofia Partsevskaya (2012)
Folic acid-modified methotrexate-conjugated PEGylated poly(ε-caprolactone) nanoparticles for targeted delivery
O. Issarachot (2014)
Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
J. G. Shiah (2000)
Clinical Applications of Polymeric Micelle Carrier Systems in Chemotherapy and Image Diagnosis of Solid Tumors
M. Yokoyama (2011)
Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.
C. Zhao (2013)
Ruthenium Anticancer Agents—From Cisplatin Analogues to Rational Drug Design
M. Adams (2017)
Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine).
M. Hashida (1998)
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
S. Jain (2008)
Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
K. Nwe (2010)
Brain targeting Drug Delivery System: A Review
Y. Mehmood (2015)
POLYMER MICELLES FOR TUNABLE DRUG RELEASE AND ENHANCED ANTITUMOR EFFICACY
Andrei Ponta (2013)
Long Circulation and Tumor Accumulation
Sandra N. Ekdawi (2013)
Chondroitin sulfate functionalized liposomes for solid tumor targeting
Rashmi Bagari (2011)
Neoglyco- and Neopeptide Albumins for Cell-Specific Delivery of Drugs to Chronically Diseased Livers
L. Beljaars (2001)
Drug Targeting with Polymeric Micelle Drug Carriers
M. Yokoyama (2002)
Study on the multirecognition mechanism of supramolecular interaction in the thiabendazole/β-cyclodextrin/Triton X-100
X. Wang (2007)
Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.
Stephanie E. A. Gratton (2007)See more